Analyst Recommendations
5.45 -0.05(-0.91%)09/16/2024
Verve Therapeutics Inc (VERV)
Verve Therapeutics Inc (VERV)
2024: Total Recommendations Consensus
To Grade | # of Recommendations |
---|---|
Buy | 4 |
Outperform | 2 |
5 records were shown. To view all data, Upgrade to PRO plan with only $1
Upgrades & Downgrades